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as being of low sensitivity, time consuming, and costly. 
They were reported for the determination of itopride 
HCl and its related substances in biological fluids like 
plasma, blood, and urine only but, not a single method 
has been reported for its determination in bulk and solid 
(tablet) dosage forms by reversed phase high-performance 
liquid chromatographic (RP-HPLC) method. This 
study was designed to develop a simple and reliable 
method to quantitate itopride HCl in a relatively short 
time with high linearity. Therefore, this study focused 
on the development of simple and rapid isocratic RP-
HPLC method which can be employed for the routine 
analysis of itopride HCl in bulk drug and formulations. 
The established method was validated with respect to 
specificity, linearity, precision, accuracy, and ruggedness.
INTRODUCTION
Itopride hydrochloride (N-[4-[2-(dimethylamino)-
ethoxy] benzyl]-3,4-dimethoxybenzamide hydrochloride) 
is a novel gastroprokinetic agent, which stimulates 
gastrointestinal motor activity through synergistic effects 
of dopamine D2 receptor blockade and acetylcholine 
esterase inhibition.[1,2] Itopride HCl is prescribed for 
the gastrointestinal symptoms caused by reduced 
gastrointestinal mobility, e.g., a feeling of gastric fullness, 
upper abdominal pain, anorexia, heartburn, nausea 
and vomiting, caused by conditions such as functional 
dyspepsia or chronic gastritis. The extraction reported 
to detect itopride HCl was liquid-liquid extraction.[3-5] 
However, this method presented some disadvantages such 
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An isocratic reversed phase high-performance liquid chromatographic method with ultraviolet detection at 220 nm 
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HCl was 100.01%. The proposed method was validated for its selectivity, linearity, accuracy, and precision. The 
method was found to be suitable for the quality control of itopride HCl in tablet dosage formulation.
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MATERIALS AND METHODS
Chemicals and reagents
All chemicals and reagents were of HPLC grade quality. 
Itopride HCl was a gift sample from Micro Labs Limited, 
Hosur, Tamilnadu, India.
Instrumentation and chromatographic conditions
An HPLC system consisted of Schimadzu UV detector, C8 
(5 µm, 250 mm × 4.6 mm) column was used for separation 
and the chromatograph were recorded using CLASS-VP 
software. The separation was carried out under isocratic 
elution with mobile phase was a mixture (75 volumes) of 
1.4 mL of ortho-phosphoric acid in 1000 mL of water and 
adjust the pH 3.0 by using triethyl amine and acetonitrile 
(25 volumes), was filtered through 0.4 µm nylon membrane 
filter before use. The flow rate was 1.0 mL min-1, the analyte 
was monitored at 220 nm, and the injection volume was 
20 µL.
Standard and sample preparation
A standard stock solution of 50 mg of itopride HCl in 
mobile phase was prepared in a volumetric flask. From 
this stock solution, about 10 mL was diluted to 100 mL 
with mobile phase.
Estimation of itopride HCl in tablet dosage form
Twenty tablets were weighed and crushed to a fine powder. 
The powder equivalent of 50 mg of itopride HCl was taken 
in a 100-mL volumetric flask containing mobile phase 
and kept sonication for 10 min and made up to mark with 
mobile phase. The resultant mixture was filtered through 
0.45 µm nylon filter. The desired concentration for the 
drug was obtained by accurate dilution, and the analysis 
was followed up as in the general analytical procedure.
RESULTS AND DISCUSSION
Development and optimization of isocratic HPLC 
conditions
A UV scan of itopride HCl showed a maximal absorbance 
at or near 220 nm. Initial method development was 
conducted on a C8 (5 µm, 250 mm × 4.6 mm) column 
was used for separation at ambient temperature. The 
chromatographic conditions were optimized with respect 
to specificity, resolution, and time of analysis. The results 
of the chromatogram were retention time = 4.217, USP 
tailing factor = 1.44, theoretical plate no. = 6144.7, 
calibration range = 80-120%, and area = 4437618. Linearity 
was studied by preparing standard solution at different 
concentration levels. The linearity range was found to be 
80-120%. The regression equation was found to be y = 
44686x with coefficient of correlation 0.9995 where x is 
concentration and y is peak area.[6] A mobile phase of a 
mixture (75 volumes) of 1.4 mL of ortho-phosphoric acid 
in 1000 mL of water and adjust the pH 3.0 by using triethyl 
amine and acetonitrile (25 volumes), was found to provide 
a reproducible, baseline resolved peak [Figures 1 and 2]. 
These conditions allowed for separation of itopride HCl 
from tablet formulation. 
Method validation
For validation of analytical methods, the guidelines of 
the International Conference on the Harmonization 
of Technical Requirements for the Registration of 
Figure 1: Chromatogram of Itopride HCl
Figure 2: Linearity graph for Itopride HClThiruvengada Rajan, et al. J Young Pharm. 2010;2(4): 410-413
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Pharmaceuticals for Human Use (ICH 1996) and (USP 
2003) have recommended the accomplishment of accuracy 
tests, precision, specificity, linearity, ruggedness, and 
robustness of the method.
Intra- and interday accuracy precision
Precision was studied to find out intra- and interday 
variations in the test methods of itopride HCl at six 
different weight levels 304.4, 305.6, 308.2, 299.1, 305.6, and 
300.1 mg two times same day and different day, respectively. 
The percentage RSD was calculated which should be 
<2%. Intraday precision was done on the same day and 
the percentage RSD was calculated, and interday precision 
was done on the different day and percentage RSD was 
calculated. The results were shown in Tables 1 and 2. 
Accuracy
Accuracy was determined by recovery study of itopride 
HCl known amount of standard itopride HCl was added 
into preanalyzed sample and subjects them to the proposed 
HPLC method. The results of recovery studies are shown 
in Table 3. The study was carried out at three different 
concentration levels.[7]
Specificity
Subjecting the drug solution in different stress conditions 
such as acid, base, and peroxide, and the degradation was 
noted.[8,9] The results were shown in Table 4. 
Robustness
This was done by small deliberate changes in the 
chromatographic conditions at three different levels -1, 
0, +1, and retention time of itopride HCl was noted. The 
factors selected were flow rate, pH, and % acetonitrile in 
the mobile phase. Results shown in Table 5 indicate that 
the selected factors remained unaffected by small variations 
of these parameters. 
CONCLUSION
A simple and reliable HPLC method for measuring itopride 
HCl in pharmaceutical dosage formulation has been 
developed. A fully validated RP-HPLC procedure for the 
assay of itopride HCl drug in tablet formulation is described 
for the first time. Hence, it can be recommended for the  Table 1: Intraday precision characteristics of itopride 
HCl
Weight of 
samples (g)
Injection volume 
(µL)
Mean area  RSD (%)
304.4 20 4429594 0.03
305.6 20 4462525 0.59
308.2 20 4568540 0.23
299.1 20 4319730 0.11
305.6 20 4395803 0.04
300.1 20 4322305 0.01
Table 2: Interday precision characteristics of itopride 
HCl
Weight of 
samples (g)
Injection volume 
(µL)
Mean  RSD (%)
304.1 20 4446587 0.40
303.7 20 4453466 0.19
307.9 20 4548451 0.00
300.3 20 4333103 0.09
302.7 20 4397236 0.14
304.1 20 4332490 0.40
Table 3: Recovery studies of itopride HCl
Labeled amount 
(mg)
Amount added 
(mg)
Amount 
recovered (mg)
% Recovery
50.0 40.40 40.38 99.95
50.0 50.90 51.30 100.79
50.0 60.10 59.68 99.29
Table 4: Specificity studies of itopride HCl
Specificity Weight of 
sample (g)
Time  
(h)
RT of itopride 
HCl
RT of degraded 
product
Acid stress
(0.5 N HCl)
0.305 0 4.300 4.308
8 4.301 4.310
Base stress
(5 N NaOH)
0.305 0 4.325 4.317
8 4.322 4.314
Peroxide stress 
(3% H2O2)
0.305 0 4.233 4.217
8 4.244 4.221
Table 5: Robustness characteristics of itopride HCl
Factor Level Retention time
Flow rate (mL/min)
0.9 -1 4.675
1.0 0 3.833
1.1 +1 3.825
pH of mobile phase
2.9 -1 3.667
3.0 0 3.675
3.1 +1 4.808
Percentage acetonitrile in the 
mobile phase
22.5 -1 3.800
25.0 0 3.792
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routine quality control of this drug. The simplicity of the 
HPLC procedure, the short run time, and the low volume 
of injection make this method suitable for quick and routine 
analysis. The intraday run and interday run variability and 
accuracy results were with in the acceptable limit. 
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